← Evidence map

ArticleJournal of thoracic disease2025

When to initiate durvalumab after concurrent chemoradiation in unresectable stage III non-small cell lung cancer?-A commentary on the phase II TORG 1937 (DATE) study.

Megan Smith-Uffen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 40223967